Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Chemical Peels and Fractional Laser on IGF-1 Levels in Skin

Massachusetts General Hospital · NCT03775031

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 55+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
20
US sites recruiting
1
Study start
December 1, 2019
Record last updated
October 22, 2020

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to evaluate the impact of fractional laser versus chemical peels on IGF-1 levels in skin.

Being studied: Fractional Laser and Chemical Peel

Conditions: Skin Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Male and female subjects >55 years old
  • Fitzpatrick type I-II
  • Able to provide informed consent.
  • Cutaneous photodamage of 3 or above on the Larnier photodamage scale (see Appendix).

Exclusion Criteria

  • Prior laser or peel treatment in the area evaluated in the current study in the past year.
  • Currently taking immunosuppressant medications known to interfere wound healing or anti-inflammatory medications (such as NSAIDs, or steroids).
  • Subjects who have underlying diseases that could alter wound healing response (such as Diabetes).
  • Currently taking insulin.
  • History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study.
  • History of abnormal scarring such as Keloids.
  • History of vitiligo.
  • Allergy or sensitivity or allergy to topical anesthesia
  • Inability to use sunscreen.
  • History of smoking in the last 10 years
  • Scar or prior surgery in the area of treatment.
  • Use of isotretinoin in the prior 6 months
  • Subjects who have bleeding disorders or who are taking anticoagulants

Recruiting US locations

  • Massachusetts General Hospital Clinical Unit for Research Trials and Outcomes in Skin

    Boston, MA 02114

    Site contact: Molly Wanner · 617-726-5066 · harvardskinstudies@partners.org

Study contacts (from the official record)

  • Molly Wanner, MD · 617-726-5066 · mwanner@mgh.harvard.edu
Chemical Peels and Fractional Laser on IGF-1 Levels in Skin (NCT03775031) | Bored Studies